Cargando…

Searching for SARS-CoV-2 in Cancer Tissues: Results of an Extensive Methodologic Approach based on ACE2 and Furin Expression

SIMPLE SUMMARY: SARS-CoV-2 is the virus that causes COVD-19; there is consensus that this virus infects cells presenting the angiotensin-converting enzyme 2 (ACE2) receptor at the cell surface. In our study, we assessed the expression profiles of cancer cells regarding the expressions of ACE2 and fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricardo, Sara, Canão, Pedro, Martins, Diana, Magalhães, Ana C., Pereira, Marina, Ribeiro-Junior, Ulysses, de Mello, Evandro Sobroza, Alves, Venâncio A., Pinto, Regina, Leitão, Dina, Alves, Georgina, Oliveira, Rute, Wilton, Joana, Costelha, Susete, Meireles, Diana, Cabanes, Didier, David, Leonor, Schmitt, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179515/
https://www.ncbi.nlm.nih.gov/pubmed/35681562
http://dx.doi.org/10.3390/cancers14112582
_version_ 1784723295267979264
author Ricardo, Sara
Canão, Pedro
Martins, Diana
Magalhães, Ana C.
Pereira, Marina
Ribeiro-Junior, Ulysses
de Mello, Evandro Sobroza
Alves, Venâncio A.
Pinto, Regina
Leitão, Dina
Alves, Georgina
Oliveira, Rute
Wilton, Joana
Costelha, Susete
Meireles, Diana
Cabanes, Didier
David, Leonor
Schmitt, Fernando
author_facet Ricardo, Sara
Canão, Pedro
Martins, Diana
Magalhães, Ana C.
Pereira, Marina
Ribeiro-Junior, Ulysses
de Mello, Evandro Sobroza
Alves, Venâncio A.
Pinto, Regina
Leitão, Dina
Alves, Georgina
Oliveira, Rute
Wilton, Joana
Costelha, Susete
Meireles, Diana
Cabanes, Didier
David, Leonor
Schmitt, Fernando
author_sort Ricardo, Sara
collection PubMed
description SIMPLE SUMMARY: SARS-CoV-2 is the virus that causes COVD-19; there is consensus that this virus infects cells presenting the angiotensin-converting enzyme 2 (ACE2) receptor at the cell surface. In our study, we assessed the expression profiles of cancer cells regarding the expressions of ACE2 and furin (another important player in the infection process). We analyzed a series of formalin-fixed paraffin-embedded samples of tumor tissues from cancer patients who underwent surgery at the beginning of the pandemic, including some cases with known positive results for SARS-CoV-2. Our goal was to explore the possibility of viral infections in cancer tissues by detecting viral RNA and/or proteins using histology-based methods. From this extensive methodologic approach, we show that colon and gastric carcinoma cells present high expression levels of ACE2 and furin, contrasting with a negative expression profile of ACE2 in thyroid carcinoma. Some cases tested positive for SARS-CoV-2 by PCR extracted from tissue sections, but in situ hybridization and immunohistochemistry did not show consistent results of a viral presence in the cancer cells. Our study raises the possibility of ACE2-mediated viral tropism for cancer tissues to be clarified in future studies. ABSTRACT: SARS-CoV-2 pandemics have been massively characterized on a global scale by the rapid generation of in-depth genomic information. The main entry gate of SARS-CoV-2 in human cells is the angiotensin-converting enzyme 2 (ACE2) receptor. The expression of this protein has been reported in several human tissues, suggesting a correlation between SARS-CoV-2 organotropism and ACE2 distribution. In this study, we selected (a series of) 90 patients who were submitted to surgery for tumor removal between the beginning of the SARS-CoV-2 pandemic and the closure of operating rooms (by the end of March 2020) in two different countries—Portugal and Brazil. We evaluated the expressions of ACE2 and furin (another important factor for virus internalization) in colon (n = 60), gastric (n = 19), and thyroid (n = 11) carcinomas. In a subseries of cases with PCR results for SARS-CoV-2 detection in the peri-operatory window (n = 18), we performed different methodological approaches for viral detections in patient tumor samples. Our results show that colon and gastric carcinomas display favorable microenvironments to SARS-CoV-2 tropism, presenting high expression levels of ACE2 and furin. From the subseries of 18 cases, 11 tested positive via PCR detection performed in tumor blocks; however, a direct association between the ACE2 expression and SARS-CoV-2 infection was not demonstrated in cancer cells using histology-based techniques, such as immunohistochemistry or in situ hybridization. This study raises the possibility of ACE2-mediated viral tropism in cancer tissues to be clarified in future studies.
format Online
Article
Text
id pubmed-9179515
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91795152022-06-10 Searching for SARS-CoV-2 in Cancer Tissues: Results of an Extensive Methodologic Approach based on ACE2 and Furin Expression Ricardo, Sara Canão, Pedro Martins, Diana Magalhães, Ana C. Pereira, Marina Ribeiro-Junior, Ulysses de Mello, Evandro Sobroza Alves, Venâncio A. Pinto, Regina Leitão, Dina Alves, Georgina Oliveira, Rute Wilton, Joana Costelha, Susete Meireles, Diana Cabanes, Didier David, Leonor Schmitt, Fernando Cancers (Basel) Article SIMPLE SUMMARY: SARS-CoV-2 is the virus that causes COVD-19; there is consensus that this virus infects cells presenting the angiotensin-converting enzyme 2 (ACE2) receptor at the cell surface. In our study, we assessed the expression profiles of cancer cells regarding the expressions of ACE2 and furin (another important player in the infection process). We analyzed a series of formalin-fixed paraffin-embedded samples of tumor tissues from cancer patients who underwent surgery at the beginning of the pandemic, including some cases with known positive results for SARS-CoV-2. Our goal was to explore the possibility of viral infections in cancer tissues by detecting viral RNA and/or proteins using histology-based methods. From this extensive methodologic approach, we show that colon and gastric carcinoma cells present high expression levels of ACE2 and furin, contrasting with a negative expression profile of ACE2 in thyroid carcinoma. Some cases tested positive for SARS-CoV-2 by PCR extracted from tissue sections, but in situ hybridization and immunohistochemistry did not show consistent results of a viral presence in the cancer cells. Our study raises the possibility of ACE2-mediated viral tropism for cancer tissues to be clarified in future studies. ABSTRACT: SARS-CoV-2 pandemics have been massively characterized on a global scale by the rapid generation of in-depth genomic information. The main entry gate of SARS-CoV-2 in human cells is the angiotensin-converting enzyme 2 (ACE2) receptor. The expression of this protein has been reported in several human tissues, suggesting a correlation between SARS-CoV-2 organotropism and ACE2 distribution. In this study, we selected (a series of) 90 patients who were submitted to surgery for tumor removal between the beginning of the SARS-CoV-2 pandemic and the closure of operating rooms (by the end of March 2020) in two different countries—Portugal and Brazil. We evaluated the expressions of ACE2 and furin (another important factor for virus internalization) in colon (n = 60), gastric (n = 19), and thyroid (n = 11) carcinomas. In a subseries of cases with PCR results for SARS-CoV-2 detection in the peri-operatory window (n = 18), we performed different methodological approaches for viral detections in patient tumor samples. Our results show that colon and gastric carcinomas display favorable microenvironments to SARS-CoV-2 tropism, presenting high expression levels of ACE2 and furin. From the subseries of 18 cases, 11 tested positive via PCR detection performed in tumor blocks; however, a direct association between the ACE2 expression and SARS-CoV-2 infection was not demonstrated in cancer cells using histology-based techniques, such as immunohistochemistry or in situ hybridization. This study raises the possibility of ACE2-mediated viral tropism in cancer tissues to be clarified in future studies. MDPI 2022-05-24 /pmc/articles/PMC9179515/ /pubmed/35681562 http://dx.doi.org/10.3390/cancers14112582 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ricardo, Sara
Canão, Pedro
Martins, Diana
Magalhães, Ana C.
Pereira, Marina
Ribeiro-Junior, Ulysses
de Mello, Evandro Sobroza
Alves, Venâncio A.
Pinto, Regina
Leitão, Dina
Alves, Georgina
Oliveira, Rute
Wilton, Joana
Costelha, Susete
Meireles, Diana
Cabanes, Didier
David, Leonor
Schmitt, Fernando
Searching for SARS-CoV-2 in Cancer Tissues: Results of an Extensive Methodologic Approach based on ACE2 and Furin Expression
title Searching for SARS-CoV-2 in Cancer Tissues: Results of an Extensive Methodologic Approach based on ACE2 and Furin Expression
title_full Searching for SARS-CoV-2 in Cancer Tissues: Results of an Extensive Methodologic Approach based on ACE2 and Furin Expression
title_fullStr Searching for SARS-CoV-2 in Cancer Tissues: Results of an Extensive Methodologic Approach based on ACE2 and Furin Expression
title_full_unstemmed Searching for SARS-CoV-2 in Cancer Tissues: Results of an Extensive Methodologic Approach based on ACE2 and Furin Expression
title_short Searching for SARS-CoV-2 in Cancer Tissues: Results of an Extensive Methodologic Approach based on ACE2 and Furin Expression
title_sort searching for sars-cov-2 in cancer tissues: results of an extensive methodologic approach based on ace2 and furin expression
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179515/
https://www.ncbi.nlm.nih.gov/pubmed/35681562
http://dx.doi.org/10.3390/cancers14112582
work_keys_str_mv AT ricardosara searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT canaopedro searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT martinsdiana searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT magalhaesanac searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT pereiramarina searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT ribeirojuniorulysses searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT demelloevandrosobroza searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT alvesvenancioa searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT pintoregina searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT leitaodina searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT alvesgeorgina searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT oliveirarute searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT wiltonjoana searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT costelhasusete searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT meirelesdiana searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT cabanesdidier searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT davidleonor searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression
AT schmittfernando searchingforsarscov2incancertissuesresultsofanextensivemethodologicapproachbasedonace2andfurinexpression